This has indeed been described previously, and in certain instances even IFN-adaptation and -dependence was observed, in which tumours “learned” to exploit protumourigenic features of ISGs while overcoming antiproliferative effects [30, 44, 89–91]. The gene discussed is IFNA1; the disease is neoplasm.